Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: Incidence and survival

Canadian Journal of Veterinary Research

Volumn 71, Issue 4, 2007, Pages 292-299

  Egenvall, Agneta ^a   Nødtvedt, Ane ^a   von Euler, Henrik ^b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BONE TUMOR; BREEDING LINE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOG DISEASE; FEMALE; GENDER BIAS; GEOGRAPHIC DISTRIBUTION; INSURANCE; MALE; NONHUMAN; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; SWEDEN;

AGE FACTORS; ANIMALS; BONE NEOPLASMS; BREEDING; DOG DISEASES; DOGS; FEMALE; INCIDENCE; INSURANCE; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; SURVIVAL ANALYSIS; SWEDEN;

CANIS FAMILIARIS;

EID: 35248855875     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dernell WS, Straw RC, Withrow SJ. Tumors of the skeletal system. In: Withrow SJ, MacEwan EG, eds. Small Animal Clinical Oncology. 3rd ed. Philadelphia: WB Saunders, 2001:378-417.
2. Dernell WS. Tumours of the skeletal system. In: Dobson JM, Lascelles BD, eds. BSAVA Manual of Canine and Feline Oncology. 2nd ed. Quedgeley, England: British Small Animal Veterinary Association, 2003:179-195.
3. Dickerson ME, Page RL, LaDue TA, et al. Retrospective analysis of axial skeleton osteosarcoma in 22 large-breed dogs. J Vet Intern Med 2001;15:120-124.
4. Hillers KR, Dernell WS, Lafferty MH, Withrow SJ, Lana SE. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc 2005;226:1364-1367.
5. Spodnick GJ, Berg J, Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc 1992;200:995-999.
6. Withrow SJ, Powers BE, Straw RC, Wilkins RM. Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res 1991;270:159-168.
7. Khanna C, Wan X, Bose S, et al.The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004;10:182-186.
8. Egenvall A, Bonnett BN, Olson P, Hedhammar A. Gender, age, breed and geographic pattern of morbidity and mortality in insured dogs during 1995 and 1996. Vet Rec 2000;146:519-525.
9. Egenvall A, Bonnett BN, Öhagen P, Olson P, Hedhammar Å, von Euler H. Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995-2002. Prev Vet Med 2005;69:109-127.
10. Egenvall A, Hedhammar Å, Bonnett BN, Olson P. Survey of the Swedish dog population: age, gender, breed, location and enrollment in animal insurance. Acta Vet Scand 1999;40:231-240.
11. Svenska djursjukhusföreningen (Swedish Animal Hospital Organisation). Diagnosregister för häst, hund och katt (Diagnostic Registry for the Horse, the Dog and the Cat). Taberg, Sweden: Tabergs Tryckeri, 1993.
12. Egenvall A, Bonnett BN, Olson P, Hedhammar Å. Gender, age and breed pattern of diagnoses for veterinary care events in insured dogs during 1996. Vet Rec 2000;146:551-557.
13. Breslow NE, Day NE, eds. Rates and rate standardisation. In: Statistical Methods in Cancer Research. Vol II. The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer, 1987:48-79.
14. Dohoo I, Wayne M, Stryhn H, eds. Modelling survival data. In: Veterinary Epidemiologic Research. Charlottetown, PEI: AVC, 2003:409-457.
15. Jongeward SJ. Primary bone tumors. Vet Clin North Am Small Anim Pract 1985;15:609-641.
16. Misdorp W, Hart AA. Some prognostic and epidemiologic factors in canine osteosarcoma. J Natl Cancer Inst 1979;62: 537-545.
17. Dobson JM, Samuel S, Milstein H, Rogers K, Wood JLN. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J Small Anim Pract 2002;43:240-246.
18. Dorn CR, Taylor DO, Schneider R, Hibbard HH, Klauber MR. Survey of animal neoplasms in Alameda and Contra Costa counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1968;40:307-318.
19. Ru G, Terracini B, Glickman LT. Host related risk factors for canine osteosarcoma. Vet J 1998;156:31-39.
20. Brodey RS, Abt DA. Results of surgical treatment in 65 dogs with osteosarcoma. J Am Vet Med Assoc 1976;168:1032-1035.
21. Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC, Gebhardt MC. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 2004;429:286-291.
22. Cooley DM, Beranek BC, Schlittler DL, Glickman NW, Glickman LT, Waters DJ. Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev 2002;11: 1434-1440.
23. Jeusette I, Detilleux J, Cuvelier C, Istasse L, Diez M. Ad libitum feeding following ovariectomy in female beagle dogs: effect on maintenance energy requirement and on blood metabolites. J Anim Physiol Anim Nutr 2004;88:117-121.
24. Jeusette I, Daminet S, Nguyen P, et al. Effect of ovariectomy and ad libitum feeding on body composition, thyroid status, ghrelin and leptin plasma concentrations in female dogs. J Anim Physiol Anim Nutr 2006;90:12-18.
25. Thompson JP, Fugent MJ. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990). J Am Vet Med Assoc 1992;200:531-533.
26. Mauldin GN, Matus RE, Withrow SJ, Patnaik AK. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 1988;2:177-180.
27. Lascelles BD, Dernell WS, Correa MT, et al. Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol 2005;12:1073-1083.
28. Jordan K, Porcheret M, Croft P. Quality of morbidity coding in general practice computerized medical records: a systematic review. Fam Pract 2004;21:396-412.
29. Egenvall A, Bonnett BN, Olson P, Hedhammar Å. Validation of computerized Swedish dog and cat insurance data against veterinary practice records. Prev Vet Med 1998;36:51-65.
30. Shyr LJ, Muggenburg BA. A comparison of the predicted risks of developing osteosarcoma for dogs exposed to 238PuO2 based on average bone dose or endosteal cell dose. Radiat Res 1992;132:13-18.
31. Langenbach A, Anderson MA, Dambach DM, Sorenmo KU, Shofer FD. Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986-1996). J Am Anim. Hosp Assoc 1998;34: 113-120.